Cancer Antigen 27.29 Test: Uses, Procedure, Results

Cancer antigen 27.29 (CA 27.29) is a blood test that monitors metastatic breast cancer. Although valuable, it has limitations in what it can detect.

PDF) An individual reference limit of the serum CEA–TPA–CA 15-3

Assessment of circulating tumor cells and serum markers for

Frontiers A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling

Frontiers Clinical validation of the novel CLIA-CA-62 assay

Cancer Antigen 27.29 Test: Uses, Procedure, Results

Frontiers Clinical validation of the novel CLIA-CA-62 assay efficacy for early-stage breast cancer detection

Frontiers Clinical validation of the novel CLIA-CA-62 assay

Specially designed for no preparation use with AIA analyzers

Tosoh Bioscience AIA-PACK™ Test Cups — Breast Cancer Marker 27.29

4 Lab Tests to Check and Monitor Breast Cancer < Personalabs

Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis

CA 15-3 Antigen - an overview

CA 15-3 (Cancer Antigen 15-3) Test: Price and Normal Range - Drlogy

Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening

Magicine Pharama - Tumor Marker Tests: Purpose, Procedure & Result